Rocephin and Sumatriptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Sumatriptan (sumatriptan succinate). Common drug interactions include anxiety among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Rocephin and Sumatriptan. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Rocephin?

Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

On Jul, 28, 2026

15 people who take Rocephin and Sumatriptan together, and have interactions are studied.

Rocephin and Sumatriptan drug interactions.

What are the common drug interactions of Rocephin and Sumatriptan, by gender? *:

female:

Anxiety
Chronic kidney disease
Renal failure (kidney dysfunction)
Pulmonary embolism (blockage of the main artery of the lung)
Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Depression
Fibromyalgia (a long-term condition which causes pain all over the body)
Headache (pain in head)
Mania (a state of abnormally elevated or irritable mood)

male:

Asthenia (weakness)
Chest discomfort
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Night sweats (sweating in night)
Productive cough
Pruritus (severe itching of the skin)
Pseudomonas test positive
Pyrexia (fever)
Secretion discharge
Sputum discoloured

What are the common drug interactions of Rocephin and Sumatriptan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

30-39:

Anxiety
Chronic kidney disease
Renal failure (kidney dysfunction)
Asthenia (weakness)
Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
Chest discomfort
Chest pain
Cough
Decreased appetite
Diarrhoea

40-49:

Pulmonary embolism (blockage of the main artery of the lung)
Drug ineffective

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)

60+:

Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
International normalised ratio increased
Pancreatitis (inflammation of pancreas)
Proteinuria (presence of protein in the urine)
Pyrexia (fever)

What are the existing conditions these people have? *

Pain: 8 people, 53.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 46.67%
Sleep Disorder: 5 people, 33.33%
Stress And Anxiety: 4 people, 26.67%
Depression: 4 people, 26.67%
High Blood Pressure: 4 people, 26.67%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 26.67%
Headache (pain in head): 3 people, 20.00%
Muscle Spasms (muscle contraction): 3 people, 20.00%
Nausea (feeling of having an urge to vomit): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rocephin and Sumatriptan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously